These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


160 related items for PubMed ID: 1856814

  • 1. The effects of cyclobenzaprine on sleep physiology and symptoms in patients with fibromyalgia.
    Reynolds WJ, Moldofsky H, Saskin P, Lue FA.
    J Rheumatol; 1991 Mar; 18(3):452-4. PubMed ID: 1856814
    [Abstract] [Full Text] [Related]

  • 2. Effects of bedtime very low dose cyclobenzaprine on symptoms and sleep physiology in patients with fibromyalgia syndrome: a double-blind randomized placebo-controlled study.
    Moldofsky H, Harris HW, Archambault WT, Kwong T, Lederman S.
    J Rheumatol; 2011 Dec; 38(12):2653-63. PubMed ID: 21885490
    [Abstract] [Full Text] [Related]

  • 3. Treatment of fibromyalgia with cyclobenzaprine: A meta-analysis.
    Tofferi JK, Jackson JL, O'Malley PG.
    Arthritis Rheum; 2004 Feb 15; 51(1):9-13. PubMed ID: 14872449
    [Abstract] [Full Text] [Related]

  • 4. A randomized trial of cyclobenzaprine for the treatment of fibromyalgia.
    Quimby LG, Gratwick GM, Whitney CD, Block SR.
    J Rheumatol Suppl; 1989 Nov 15; 19():140-3. PubMed ID: 2481741
    [Abstract] [Full Text] [Related]

  • 5. The effect of zolpidem in patients with fibromyalgia: a dose ranging, double blind, placebo controlled, modified crossover study.
    Moldofsky H, Lue FA, Mously C, Roth-Schechter B, Reynolds WJ.
    J Rheumatol; 1996 Mar 15; 23(3):529-33. PubMed ID: 8832997
    [Abstract] [Full Text] [Related]

  • 6. The plasma endorphin, prostaglandin and catecholamine profile of patients with fibrositis treated with cyclobenzaprine and placebo: a 5-month study.
    Hamaty D, Valentine JL, Howard R, Howard CW, Wakefield V, Patten MS.
    J Rheumatol Suppl; 1989 Nov 15; 19():164-8. PubMed ID: 2532682
    [Abstract] [Full Text] [Related]

  • 7. [Fluoxetin combined with cyclobenzaprine in the treatment of fibromyalgia].
    Cantini F, Bellandi F, Niccoli L, Di Munno O.
    Minerva Med; 1994 Mar 15; 85(3):97-100. PubMed ID: 8196850
    [Abstract] [Full Text] [Related]

  • 8. A randomized, double-blind, placebo-controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications.
    Holman AJ, Myers RR.
    Arthritis Rheum; 2005 Aug 15; 52(8):2495-505. PubMed ID: 16052595
    [Abstract] [Full Text] [Related]

  • 9. Effects of low power laser and low dose amitriptyline therapy on clinical symptoms and quality of life in fibromyalgia: a single-blind, placebo-controlled trial.
    Gür A, Karakoc M, Nas K, Cevik R, Sarac J, Ataoglu S.
    Rheumatol Int; 2002 Sep 15; 22(5):188-93. PubMed ID: 12215864
    [Abstract] [Full Text] [Related]

  • 10. The effects of sodium oxybate on clinical symptoms and sleep patterns in patients with fibromyalgia.
    Scharf MB, Baumann M, Berkowitz DV.
    J Rheumatol; 2003 May 15; 30(5):1070-4. PubMed ID: 12734908
    [Abstract] [Full Text] [Related]

  • 11. Effects of selective slow wave sleep disruption on musculoskeletal pain and fatigue in middle aged women.
    Lentz MJ, Landis CA, Rothermel J, Shaver JL.
    J Rheumatol; 1999 Jul 15; 26(7):1586-92. PubMed ID: 10405949
    [Abstract] [Full Text] [Related]

  • 12. Cyclobenzaprine with ibuprofen versus ibuprofen alone in acute myofascial strain: a randomized, double-blind clinical trial.
    Turturro MA, Frater CR, D'Amico FJ.
    Ann Emerg Med; 2003 Jun 15; 41(6):818-26. PubMed ID: 12764337
    [Abstract] [Full Text] [Related]

  • 13. The effects of bright light treatment on the symptoms of fibromyalgia.
    Pearl SJ, Lue F, MacLean AW, Heslegrave RJ, Reynolds WJ, Moldofsky H.
    J Rheumatol; 1996 May 15; 23(5):896-902. PubMed ID: 8724305
    [Abstract] [Full Text] [Related]

  • 14. A double-blind crossover study of two cyclobenzaprine regimens in primary fibromyalgia syndrome.
    Santandrea S, Montrone F, Sarzi-Puttini P, Boccassini L, Caruso I.
    J Int Med Res; 1993 May 15; 21(2):74-80. PubMed ID: 8243792
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Alpha sleep characteristics in fibromyalgia.
    Roizenblatt S, Moldofsky H, Benedito-Silva AA, Tufik S.
    Arthritis Rheum; 2001 Jan 15; 44(1):222-30. PubMed ID: 11212164
    [Abstract] [Full Text] [Related]

  • 18. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder.
    Arnold LM, Lu Y, Crofford LJ, Wohlreich M, Detke MJ, Iyengar S, Goldstein DJ.
    Arthritis Rheum; 2004 Sep 15; 50(9):2974-84. PubMed ID: 15457467
    [Abstract] [Full Text] [Related]

  • 19. Behavioral effects of cyclobenzaprine.
    Messiha FS, Barnes CD, Hughes MJ, Light KE.
    Proc West Pharmacol Soc; 1979 Sep 15; 22():31-5. PubMed ID: 574646
    [No Abstract] [Full Text] [Related]

  • 20. Sleep and symptoms in fibrositis syndrome after a febrile illness.
    Moldofsky H, Saskin P, Lue FA.
    J Rheumatol; 1988 Nov 15; 15(11):1701-4. PubMed ID: 3236304
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.